Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

<p><strong>Background:</strong> Molnupiravir and nirmatrelvir-ritonavir (Paxlovid) are oral antivirals that have been proposed as treatments for patients admitted to hospital with COVID-19.</p> <br> <p><strong>Methods:</strong> In this randomised, cont...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ: RECOVERY Collaborative Group, Horby, PW, Staplin, N, Peto, L, Emberson, JR, Campbell, M, Pessoa-Amorim, G, Basnyat, B, Thwaites, L, Van Doorn, R, Hamers, RL, Nel, J, Amuasi, J, Stewart, R, Ghosh, D, Hamilton, F, Desai, P, Easom, N, Majumdar, J, Hine, P, Chadwick, D, Cooke, G, Sharp, S, Esmail, H, Baillie, JK, Buch, MH, Faust, SN, Jaki, T, Jeffery, K, Juszczak, E, Knight, M, Lim, WS, Montgomery, A, Mukherjee, A, Mumford, A, Rowan, K, Thwaites, G, Mafham, M, Haynes, R, Landray, MJ
Ձևաչափ: Internet publication
Լեզու:English
Հրապարակվել է: 2024

Նմանատիպ նյութեր